(MENAFN) Global firms among all sectors welcome the Saudi's "Vision 2030" initiative drawing the plans to achieve a thriving economy and a vibrant society.
Furthermore, among those global healthcare leader is MSD Saudi Arabia, which is also known as Merck in US and Canada.
The company spends close to USD7bn yearly on 18 percent of its sales on research and development, which is one of the highest in the industry.
Accordingly, the main goal for the firm is in solving for unmet medical needs amid its leading R & D products and team.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.